- Rating
- 2
- Confidence
- 3
- Informativeness
- 3
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This paper introduces Spatiotemporal Interventional Generation, a task for forecasting future medical image states under treatment conditions and temporal constraints. The authors propose SIGMA, a unified generation-understanding framework that combines biomarker-aware perception and trajectory retrieval to predict future OCT images with clinical rationales. They also construct the Ophtha-SIG benchmark for longitudinal intervention-aware forecasting. Experiments show strong performance in image prediction, rationale generation, and cross-modal consistency. Overall, the paper presents an interesting direction for longitudinal medical AI, although some concerns remain regarding causal interpretation and evaluation methodology.
Critical strengths
The main strength of this paper is the introduction of a new and clinically meaningful task formulation for longitudinal medical image forecasting. Moving beyond static diagnosis and image editing, the proposed SIG setting explicitly models future disease evolution under treatment conditions, which is an important step toward more proactive medical AI systems. Another significant strength is the construction of the Ophtha-SIG benchmark, which provides longitudinal OCT data with intervention information, biomarker transitions, and clinical rationales, enabling systematic evaluation of this emerging problem.
Critical weaknesses
A key weakness of this paper is that the term “interventional” may overstate the causal interpretation supported by the current experimental setting. Since the dataset is constructed from retrospective observational records, the model primarily learns treatment-conditioned future prediction rather than estimating counterfactual outcomes under explicit interventions. This distinction is important for the claimed clinical implications. In addition, the comparison with existing multimodal baselines is not fully conclusive because SIGMA is fine-tuned on the proposed benchmark while the extent of task-specific adaptation for competing methods is unclear. These issues make it difficult to determine whether the gains come from the proposed framework itself or from the additional supervision and benchmark specialization.
Questions for authors
- SIGMA is fine-tuned on the Ophtha-SIG benchmark, while several baseline models appear to be evaluated without equivalent task-specific adaptation. Could the authors provide results for fine-tuned versions of the strongest baselines under the same training protocol to better isolate the contribution of the proposed framework?
- The clinical rationales are generated using an LLM and filtered by biomarker consistency checks. Could the authors provide more details on the degree of expert involvement in rationale validation and discuss how they ensure that improvements in rationale metrics reflect genuine clinical reasoning rather than similarity to LLM-generated references?